QLGN Qualigen Therapeutics Inc
Market Cap
5.85M
Day’s Range
52W Range
Volume (3M)
238.97K
Price-Earnings Ratio
-
Revenue
5.07M
Qualigen Therapeutics Inc Latest News
Qualigen Therapeutics, Inc.: Qualigen Therapeutics Chief Executive Officer Michael Poirier Provides Letter to StockholdersFinanz Nachrichten2 days ago
Qualigen Therapeutics Chief Executive Officer Michael Poirier Provides Letter to StockholdersBioSpace3 days agoQualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302BioSpace11 days agoAbout Qualigen Therapeutics Inc
Qualigen Therapeutics is a healthcare firm based in California and operating in the US. Launched in 1996, the company is traded on the NASDAQ CM using the ticker QLGN. It specialises in developing and commercialising therapeutic products for treating various infectious diseases and cancer. Find the latest QLGN stock news with eToro
Show More46
Employees
Carlsbad, California, US
HQ
2004
Founded
Michael S. Poirier
CEO
People Also Bought
AIHS Senmiao Technology Ltd 6.35% 
AYTU Aytu BioScience Inc -0.46% 
DGLY Digital Ally Inc -0.97% 
TRVN Trevena Inc -5.95% 
TTNP Titan Pharmaceuticals Inc 0.45% 
VISL Vislink Technologies Inc 4.96% 
IVVD Invivyd Inc -7.89% 
ICLK iClick Interactive Asia Group ADR -1.52%